|
Jul 23
|
Nanotechnology in medicine: Who are the leading public companies?
|
|
Jul 19
|
Bausch Health Welcomes Two New Members to the Executive Leadership Team
|
|
Jun 20
|
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
|
|
May 15
|
RBC Notes Updates on Bausch Xifaxan Patent Litigation with Norwich
|
|
May 15
|
Bausch Health Announces 2024 Annual Meeting of Shareholder Results
|
|
May 14
|
Bausch Health Down 6.6% In US After Hours As Updates Related to Norwich XIFAXAN Matters
|
|
May 14
|
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
|
|
May 13
|
RBC Noes Bausch Health Filing For Rehearing in Appellate Court
|
|
May 9
|
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
|
|
May 6
|
Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week
|
|
May 3
|
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
|
|
May 2
|
Why Bausch Health Companies Stock Dived by More Than 7% Today
|
|
May 2
|
Bausch Health Companies Inc Reports Q1 2024 Earnings: A Detailed Analysis Compared to Analyst ...
|
|
May 2
|
Bausch Health (BHC) Q1 Earnings and Revenues Miss Estimates
|
|
May 2
|
Bausch Health Announces First Quarter 2024 Results
|
|
May 1
|
Bausch + Lomb Q1 Net Loss Widens, But Revenue Higher; Raises 2024 Revenue Growth Guidance
|
|
Apr 29
|
All You Need to Know About Bausch (BHC) Rating Upgrade to Buy
|
|
Apr 25
|
Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
|